Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 350-355

  Yasunari, Kenichi ^a   Kohno, Masakazu ^b   Kano, Hiroaki ^b   Yokokawa, Koji ^b   Minami, Mieko ^b   Yoshikawa, Junichi ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

dopamine; hypertrophy; platelet derived growth factor; vascular smooth muscle

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 (3,4 DIHYDROXYPHENYL) 1,2,3,4 TETRAHYDRO 7,8 DIHYDROXYISOQUINOLINE; 8 BROMO CYCLIC AMP; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PLATELET DERIVED GROWTH FACTOR BB; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL SIZE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031028693     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.350     Document Type: Article

References (34)

1. Dzau VJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol. 1988;62:30G-35G.
2. Owens GK, Reidy M. Hyperplastic growth response of vascular smooth muscle cells following indication of acute hypertension in rats by aortic coarctation. Circ Res. 1985;57:695-705.
3. Benem RD. An autoradiographic and pathologic study of cellular proliferation in rabbit arteries correlated with an increase in arterial pressure. Blood Vessels. 1976;13:100-128.
4. Owens GK, Schwartz SM. Alteration in vascular smooth muscle mass in spontaneously hypertensive rat. Circ Res. 1982;51:280-289.
5. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res. 1983; 53:491-501.
6. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell. 1986;46:155-169.
7. Ali S, Dorn II GW. Pattern of tyrosine phosphorylation differ in vascular hypertrophy and hyperplasia. Am J Physiol. 1994;267: C1674-C1681.
8. Stoof JC, Kebabian JW. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1983;35:2281-2296.
9. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Anna Rev Neurosci. 1993;16:299-321.
10. Sibley DR, Monsma FJ. Molecular biology of dopamine receptors. Trends Pharmacol Sci. 1992;13:61-69.
11. Seeman P, Van Tol HHM. Dopamine receptor pharmacology. Trends Pharmacol Sci. 1994;15:264-270.
12. 125I-Sch 23982. Am J Physiol. 1988;255:F970-F976.
13. Yasunari K, Kohno M, Balmforth AJ, Murakawa K, Yokokawa K, Kurihara N, Takeda T. Glucocorticoids and dopamine-I receptors on vascular smooth muscle cells. Hypertension. 1989;13:575-581.
14. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 1990; 86:1690-1697.
15. Abell TJ, Richard AM, Ikram H, Espiner EA, Yamdle Y. Atrial factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun. 1989;160:1392-1396.
16. Takenaka T, Forster H, Epstein M. Characterization of the renal microvascular actions of a new dopaminergic (DA 1) agonist YM 435 J Pharmacol Exp Ther. 1993;264:1154-1159.
17. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Takeda T. Effect of glucocorticoid on prostaglandin E1 mediated cyclic AMP formation by vascular smooth muscle cells. J Hypertens 1988;6: 1023-1028.
18. Yasunari K, Kanayama Y, Kohno M, Murakawa K, Kawarabayashi T, Takeda T. Central α2 adrenergic stimulation increases neurointermediate lobe immunoreactive β-endorphin in spontaneously hypertensive rat. Hypertension. 1987;9:566-570.
19. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Takeda T. Glucocorticoids and atrial natriuretic peptide receptors on vascular smooth muscle. Hypertension. 1990;16:581-586.
20. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Horio T, Takeda T. Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle. Hypertension. 1992;19:314-319.
21. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension. 1996;28:159-168.
22. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol. 1995; 15:2207-2212.
23. Ferby IM, Waga I, Sakanaka C, Kume K, Shimizu T, Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J Biol Chem. 1994; 269:30485-30488.
24. Wallenstein SW, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
25. Chijima T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. Inhibition of forskolin-induced neunte outgrowth and protein phosphorylation by newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89) of PC12D pheochromocytoma cells. J Biol Chem. 1990; 265:5267-5272.
26. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension. 1983;5:86-99.
27. Bühler HU, Prada MD, Haefely W, Picotti GB. Plasma adrenaline, noradrenaline and dopamine in man and different animal species J Physiol. 1978;276:311-320.
28. Kuchel O, Buu NT, Fontaine A, Hamet P, Beroniade V, Larochelle P. Genest J. Free and conjugated plasma catecholamines in hypertensive patients with or without pheochromocytoma Hypertension. 1980;2:177-186.
29. Yoshizumi M, Ishimura Y, Masuda Y, Ohuchi T, Katoh I, Houchi H, Oka M. Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies. Hypertens Res. 1995; 18(suppl 1):S101-S106.
30. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Horio T, Takeda T. Interaction between a phorbol ester and dopamine DA1 receptors on vascular smooth muscle. Am J Physiol. 1993:264(Renal Fluid Electrolyte Physiol 33):F24-F30.
31. Yasunari K, Kohno M, Yokokawa K, Horio T, Takeda T. Dopamine DA, receptors on vascular smooth muscle cells are regulated glucocorticoid and sodium chloride. Am J Physiol. 1994;267: R628-R634.
32. 2 stimulated mitogenesis of coronary artery smooth muscle cell involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem. 1994;269:5693-5698.
33. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama M. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells Circ Res. 1992;71:620-630.
34. Graves LM, Bornfeldt KE, Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A. 1993;90:10300-10304.